Abstract
Despite increasing calls for diversity in clinical trial recruitment, data are lacking regarding disparities in access to dermatologic clinical trials. The objective of this study was to characterize travel distance and time to reach a dermatology clinical trial site considering patient demographic and location characteristics. We determined travel distance and time from every census tract population center in the United States to the nearest dermatologic clinical trial site using ArcGIS and linked travel estimates to demographic characteristics in each census tract based on 2020 American Community Survey. Nationally, patients travel an average of 14.3 miles and 19.7 min to reach a dermatologic clinical trial site. Significantly shorter travel distance and time were observed for urban and Northeast residence, White and Asian race and private insurance relative to rural and Southern residence, Native American and Black race and public insurance (p < 0.001). These findings reveal disparate access regarding geographic region, rurality, race and insurance type, which may encourage investigators to allocate funding for travel assistance for underrepresented and disadvantaged groups to promote access and diversity in dermatologic clinical trials.
References
Elston DM (2022) Letter from the editor: diversity and inclusion in clinical trials. J Am Acad Dermatol 87(5):981–982
Feng H, Berk-Krauss J, Feng PW, Stein JA (2018) Comparison of dermatologist density between urban and rural counties in the United States. JAMA Dermatol 154(11):1265–1271
Wolfe MK, McDonald NC, Holmes GM (2020) Transportation barriers to health care in the United States: findings from the national health interview survey, 1997–2017. Am J Public Health 110(6):815–822
Kamal K, Imadojemu S, Charrow A (2022) Why diversity in dermatology clinical trials should no longer be optional: dismantling structural racism in dermatology. JAMA Dermatol 158(4):353–354
Charrow A, Xia FD, Joyce C, Mostaghimi A (2017) Diversity in dermatology clinical trials: a systematic review. JAMA Dermatol 153(2):193–198
Funding
None.
Author information
Authors and Affiliations
Contributions
EJB completed data collection and wrote the main manuscript text. JM completed analyses and prepared Table 1 and Figure 1. HF conceived the project. All authors reviewed the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
Hao Feng has consulted for Cytrellis Biosystems, Inc. and Soliton, Inc. The other authors report no conflicts of interest.
IRB approval status
This study did not qualify as human subjects research; therefore, institutional review board approval was not required at the University of Connecticut Health Center.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Beltrami, E.J., Masison, J. & Feng, H. Travel distance and time to dermatology clinical trial sites: a cross-sectional geospatial analysis. Arch Dermatol Res 315, 1461–1464 (2023). https://doi.org/10.1007/s00403-023-02590-w
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00403-023-02590-w